Study title: Clinical Certificate for MA Renewal in Slovenia - Verdoncq B. - 10 July 2007 (0703-CC-RIF+ISO+PYR-SLOVENIA-BV-10.07.07)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Bacterial Infections and Mycoses | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE | |||||
ATC code: JO4AM05 | |||||
Document link: | |||||
Document date: | |||||
Study number: EXPCRC-CES0703-EN-E01 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |